Taysha Gene Therapies, Inc.

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total revenue	0.01	0.01	0.02	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.00	0.00	0.00	0.00
Gross profit	0.01	0.01	0.02	0.00	0.00	0.00
Total operating expenses +	0.12	0.10	0.09	0.13	0.17	0.04	0.00
Selling, general and administrative	0.03	0.03	0.03	0.04	0.04	0.01	0.00
Research and development	0.09	0.07	0.06	0.09	0.13	0.03	0.00
Other operating expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating income	-0.11	-0.09	-0.07	-0.13	-0.17	-0.04	0.00
Non-operating income (net)	0.00	0.00	-0.04	-0.04	0.00	-0.02	0.00
Income before tax	-0.11	-0.09	-0.11	-0.17	-0.17	-0.06	0.00
Income tax expense		-0.09	0.00	0.00	0.00	-0.02	0.00
Net income	-0.11	-0.09	-0.11	-0.17	-0.17	-0.04	0.00

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19
Total revenue	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.00	0.00		0.00		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross profit	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total operating expenses +	0.04	0.03	0.03	0.03	0.02	0.02	0.03	0.02	0.03	0.02	0.02	0.03	0.02	0.02	0.03	0.03	0.05	0.05	0.05	0.04	0.03	0.02	0.02	0.00	0.01	0.00
Selling, general and administrative	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Research and development	0.03	0.02	0.03	0.02	0.02	0.02	0.01	0.02	0.02	0.01	0.01	0.02	0.01	0.01	0.02	0.02	0.04	0.04	0.04	0.03	0.02	0.01	0.01	0.00	0.01	0.00
Other operating expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating income	-0.04	-0.03	-0.03	-0.03	-0.02	-0.02	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.06	-0.03	-0.03	-0.05	-0.05	-0.05	-0.04	-0.03	-0.02	-0.02	0.00	-0.01	0.00
Non-operating income (net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	-0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.00
Income before tax	-0.04	-0.03	-0.03	-0.03	-0.02	-0.02	-0.03	-0.02	-0.02	0.05	-0.12	-0.02	-0.02	-0.06	-0.03	-0.03	-0.05	-0.05	-0.05	-0.04	-0.03	-0.02	-0.02	-0.02	-0.01	0.00
Income tax expense						0.00			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.00
Net income	-0.04	-0.03	-0.03	-0.03	-0.02	-0.02	-0.03	-0.02	-0.02	0.05	-0.12	-0.02	-0.02	-0.06	-0.03	-0.03	-0.05	-0.05	-0.05	-0.04	-0.03	-0.02	-0.02	-0.02	-0.01	0.00

5 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total cash and short-term investments +	0.32	0.14	0.14	0.09	0.15	0.25	0.00
Cash and cash equivalents	0.32	0.14	0.14	0.09	0.15	0.25
Short-term investments
Other current assets	0.00	0.00	0.01	0.01	0.01	0.01	0.00
Total current assets	0.32	0.14	0.15	0.10	0.16	0.26	0.00
Total non-current assets +	0.02	0.02	0.02	0.03	0.05	0.00	0.00
Property, plant and equipment, net					0.05	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.34	0.16	0.17	0.13	0.21	0.26	0.00

Total current liabilities +	0.03	0.03	0.04	0.06	0.05	0.01	0.00
Accounts payable	0.01	0.00	0.01	0.01	0.02	0.00
Short-term debt		0.00	0.00	0.00
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.02	0.01	0.01	0.02	0.03	0.01	0.00
Total non-current liabilities +	0.07	0.06	0.06	0.06	0.07	0.00	0.00
Long-term debt	0.05	0.04	0.04	0.04	0.04
Capital lease obligations	0.02	0.02	0.02	0.02	0.03	0.00
Other non-current liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total liabilities	0.10	0.09	0.10	0.13	0.12	0.01	0.00

Total stockholders' equity +	0.25	0.07	0.07	0.00	0.10	0.25	0.00
Common stock and paid-in capital	0.96	0.67	0.59	0.40	0.33	0.31	0.00
Retained earnings	-0.71	-0.60	-0.51	-0.40	-0.24	-0.06	0.00
Common shares outstanding	320	250	116	44	38	18	37

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19
Total cash and short-term investments +	0.28	0.32	0.30	0.31	0.12	0.14	0.16	0.17	0.12	0.14	0.16	0.05	0.06	0.09	0.03	0.07	0.10	0.15	0.19	0.20	0.23	0.25	0.28	0.01	0.00	0.00
Cash and cash equivalents	0.28	0.32	0.30	0.31	0.12	0.14	0.16	0.17	0.12	0.14	0.16	0.05	0.06	0.09	0.03	0.07	0.10	0.15	0.19	0.20	0.23	0.25	0.28	0.01
Short-term investments
Other current assets	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Total current assets	0.28	0.32	0.30	0.32	0.12	0.14	0.16	0.18	0.13	0.15	0.17	0.05	0.07	0.10	0.04	0.08	0.11	0.16	0.20	0.21	0.24	0.26	0.28	0.01	0.01
Total non-current assets +	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.07	0.07	0.06	0.05	0.04	0.03	0.00	0.00	0.00	0.00
Property, plant and equipment, net												0.01	0.01	0.03	0.06	0.06	0.06	0.05	0.04	0.03	0.00	0.00	0.00	0.00	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.30	0.34	0.32	0.33	0.14	0.16	0.18	0.20	0.15	0.17	0.20	0.08	0.10	0.13	0.11	0.14	0.17	0.21	0.24	0.24	0.24	0.26	0.28	0.01

Total current liabilities +	0.02	0.03	0.03	0.03	0.02	0.03	0.03	0.03	0.04	0.04	0.18	0.05	0.05	0.06	0.03	0.04	0.05	0.05	0.04	0.03	0.02	0.01	0.01	0.02	0.02
Accounts payable	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.01	0.00	0.00	0.01	0.00	0.00
Short-term debt			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00										0.02
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.15	0.02	0.01	0.02	0.02	0.02	0.03	0.03	0.02	0.02	0.01	0.01	0.00	0.00
Total non-current liabilities +	0.07	0.07	0.07	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.07	0.06	0.06	0.07	0.07	0.07	0.07	0.06	0.03	0.00	0.00	0.01	0.00
Long-term debt	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03
Capital lease obligations	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03
Other non-current liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.03	0.03	0.03	0.00	0.03	0.00	0.00	0.00
Total liabilities	0.09	0.10	0.10	0.08	0.08	0.09	0.09	0.09	0.10	0.10	0.24	0.12	0.12	0.13	0.10	0.11	0.12	0.12	0.10	0.06	0.02	0.01	0.01	0.02

Total stockholders' equity +	0.21	0.25	0.22	0.25	0.06	0.07	0.09	0.11	0.05	0.07	-0.05	-0.04	-0.01	0.00	0.01	0.03	0.05	0.10	0.14	0.19	0.22	0.25	0.27	-0.01	0.00
Common stock and paid-in capital	0.97	0.96	0.90	0.90	0.68	0.67	0.67	0.67	0.59	0.59	0.51	0.41	0.40	0.40	0.36	0.35	0.34	0.33	0.33	0.32	0.32	0.31	0.31	0.02	0.03	0.00
Retained earnings	-0.75	-0.71	-0.68	-0.65	-0.62	-0.60	-0.58	-0.56	-0.54	-0.51	-0.56	-0.44	-0.42	-0.40	-0.35	-0.32	-0.29	-0.24	-0.19	-0.13	-0.09	-0.06	-0.04	-0.03	-0.03
Common shares outstanding	367	320	353	298	269	205	268	233	231	187	126	64	63	56	41	40	38	38	38	37	37	38	12	35	15	15

5 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Operating cash flow +	-0.09	-0.08	-0.07	-0.09	-0.12	-0.03	0.00
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.01	0.01	0.01	0.02	0.02	0.00
Change in inventory
Other working capital changes	-0.11	-0.10	-0.08	-0.11	-0.14	-0.03	0.00
Cash flow from investing +	0.00	0.00	-0.01	-0.02	-0.02	-0.01	-0.01
Capital expenditures	0.00	0.00	-0.01	-0.02	-0.02	-0.01	0.00
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00	0.00	-0.01
Cash flow from financing +	0.27	0.08	0.14	0.05	0.04	0.29	0.29
Dividend payout
Common stock repurchases						0.29
Net Debt Issuance	0.27	0.08	0.14	0.05	0.04	0.00	0.29

Change in cash	0.18	0.00	0.06	-0.06	-0.10	0.25	0.28

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19
Operating cash flow +	-0.04	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	0.01	-0.03	-0.03	-0.04	-0.04	-0.03	-0.02	-0.02	-0.02	-0.01	0.00	0.00	0.00
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.00	0.00
Change in inventory
Other working capital changes	-0.05	-0.03	-0.03	-0.02	-0.03	-0.02	-0.03	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	0.01	-0.03	-0.04	-0.05	-0.05	-0.04	-0.03	-0.03	-0.02	-0.01	0.00	0.00	0.00
Cash flow from investing +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01	-0.01	0.00	-0.01	0.00	-0.01	0.00	0.00	0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01	-0.01	0.00	-0.01	0.00	-0.01	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	0.00	0.05	0.01	0.22	0.00	0.00	0.01	0.07	0.00	0.00	0.14	0.00	0.00	0.04	0.00	0.01	0.00	0.01	0.03	0.03	0.00	0.00	0.27	0.00	0.02
Dividend payout
Common stock repurchases			0.00							0.00		0.00	0.00		0.00	0.01						0.00
Net Debt Issuance	0.00	0.05	0.01	0.22	0.00	0.00	0.01	0.07	0.00	0.00	0.14	0.00	0.00	0.04	0.00	0.00	0.00	0.01	0.03	0.03	0.00	0.00	0.27	0.00	0.02	0.00

Change in cash	-0.04	0.02	-0.02	0.20	-0.02	-0.02	-0.02	0.05	-0.02	-0.02	0.12	-0.02	-0.02	0.06	-0.03	-0.03	-0.05	-0.04	-0.01	-0.01	-0.02	-0.03	0.27	-0.01	0.01	0.00